PRELAJ, ARSELA
 Distribuzione geografica
Continente #
NA - Nord America 609
EU - Europa 129
AS - Asia 78
AF - Africa 2
Totale 818
Nazione #
US - Stati Uniti d'America 603
IT - Italia 51
SE - Svezia 46
IN - India 30
CN - Cina 26
SG - Singapore 21
FI - Finlandia 11
DE - Germania 7
CA - Canada 6
RO - Romania 6
IE - Irlanda 4
BG - Bulgaria 3
TG - Togo 2
TR - Turchia 1
UA - Ucraina 1
Totale 818
Città #
Fairfield 115
Seattle 67
Chandler 51
Woodbridge 51
Ashburn 49
Cambridge 47
Wilmington 38
Houston 27
Rome 17
Princeton 15
Singapore 12
Plano 11
Beijing 10
Lawrence 10
San Paolo di Civitate 10
Helsinki 9
Ann Arbor 8
Dearborn 8
San Diego 7
Boston 5
Marcallo con Casone 5
Millbury 5
Dublin 4
Chicago 3
Fremont 3
Mannheim 3
Norwalk 3
Olgiate Olona 3
Ottawa 3
Sofia 3
Toronto 3
Anantapur 2
Bremen 2
Hefei 2
Lomé 2
Nanjing 2
New York 2
Phoenix 2
Andover 1
Casoria 1
Des Moines 1
Falls Church 1
Fuzhou 1
Guangzhou 1
Hyderabad 1
Istanbul 1
Jinan 1
Leawood 1
Los Angeles 1
Milan 1
Redmond 1
Redwood City 1
Sacramento 1
Tianjin 1
Wuhan 1
Totale 636
Nome #
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature 110
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: efficacy and safety in clinical practice 85
M8Concomitant versus sequential Fotemustine and Bevacizumab in recurrent malignant gliomas: treatment response and survival outcomes in a retrospective analysis 81
Multimodal treatment for local recurrent malignant gliomas: resurgery and/or reirradiation followed by chemotherapy 75
Neoadjuvant chemotherapy in neuroendocrine bladder cancer: a case report 74
Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: case report and review of the literature 69
S47A retrospective analysis to evaluted the off-label use Bevacizumab in recurrent malignant gliomas 63
AIOM abstracts - IMPACT OF MULTIDISCIPLINARY BASELINE EVALUATION FOR THYMIC EPITHELIAL TUMORS: EXPERIENCE FROM AN ITALIAN REFERENCE CENTER 59
94P: First-line treatment with cisplatin plus etoposide for small cell lung cancer and large cell neuroendocrine carcinoma: Our center experience 54
null 47
1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program 37
null 33
Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasia 31
Radium-223 in metastatic castration-resistant prostate cancer (mCRPC):efficacy and safety in real-life experience 28
Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomas 11
Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC 11
Totale 868
Categoria #
all - tutte 2.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 23 4 2 10 32 32 35 32 31 18 10 13
2020/202197 7 8 2 3 1 29 8 4 7 23 2 3
2021/2022123 0 5 7 8 21 4 2 17 7 6 24 22
2022/2023168 26 30 10 17 22 11 7 22 19 2 2 0
2023/202492 8 11 7 4 21 7 6 1 2 8 8 9
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 868